Supervision of individual transactions ‘no longer’ needed, cross-sector group finds

A cross-sector group has developed legislative recommendations to tighten up the concept of supervision in community pharmacy.

Supervising every transaction is "no longer suitable for modern practice"

Pharmacy “supervision” should not mean supervising individual transactions, according to the Supervision Practice Group – a cross-sectoral working group formed to provide recommendations to the government regarding the nature of supervision in pharmacy.

Free to registered users

Register to gain full access to C+D and C+D Community content

Sign in or register for free

James Stent

Read more by James Stent

James Stent joined C+D as a digital reporter in May 2023 from the South African human rights news agency GroundUp, where he was senior reporter and consultant editor.

Latest from News

New primary care medical director role as 2-year NHSE axing begins

 
• By 
 • comment

Wes Streeting has revealed that the DH is “immediately” working to scrap NHS England (NHSE) and put a new “transformation team” in place – adding that it is in the “very final stages” of concluding a new pharmacy contract deal.

‘Devastating news’: Alliance puts ‘upwards of 845’ jobs at risk

 
• By 
 • comment

Alliance Healthcare has revealed “plans to close” two Midlands service centres and proposed cuts at another, putting hundreds of jobs at risk.

IN FULL: Starmer reveals plans to abolish NHSE

 
• By 
 • comment

Prime Minister Keir Starmer has announced that NHS England will be abolished to bring the management of the NHS “back into democratic control”.

More from Business

breaking news

IN FULL: Boots’ parent company sold in $24bn private equity deal

 
• By 
 • comment

Walgreens Boots Alliance (WBA) has “entered into a definitive agreement to be acquired” by private equity firm Sycamore Partners.

Jhoots accounts: Shareholder funds tumble while debts soar

 
• By 
 • comment

Jhoots Chemist’s accounts for 2024 have revealed an almost £2 million year-on-year dip in shareholder funds – as debts to creditors increase more than £2m.